These data indicate that L-DOPA does not induce modifications of DAT expression detectable by SPECT of by DAT binding autoradiography, suggesting that differences between clinical assessment and radiotracer imaging in clinical trials may not be specifically related to L-DOPA treatment.
No takes yet. Share an insight, caveat, or question.
Fernagut et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: